BIRMINGHAM, Ala. (AP) -- The state Supreme Court is reconsidering a decision allowing makers of name brand drugs to be held liable for injuries caused by generic versions that are made by different companies.
Reports say the court has announced oral arguments will be held in September. This comes in response to the makers of an acid reflux drug requesting that the court reverse an opinion it issued in January.
Pfizer Inc. officials have said the court's first decision was made without oral arguments being presented in the case.
The company will argue that drug makers should not be held liable for injuries caused by products they didn't manufacture. In a statement, Pfizer's Senior Vice President Michael Parini, said the state court's decision is contrary to that of federal appeals courts.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.